Yesterday
- Exclusive
- Healthcare
Health insurers baulk at Labor pitch to expand maternity cover
Changes floated by the Health Department include forcing funds to pay more for hospital-in-the-home programs to take pressure off private hospitals.
- Michael Smith
This Month
Why it’s a bad year for holidaymakers bringing flu home from Europe
Australians holidaying in the northern hemisphere are returning with nasty strains of influenza which experts blame on low immunisation rates since the COVID-19 pandemic.
- Michael Smith
The doctor on a crusade to help menopausal women ‘get their lives back’
Mary Claire Haver, an obstetrician and gynaecologist, has built a multimillion-dollar business advising women on how to navigate menopause. But not everyone is a fan.
- Danielle Friedman
Ozempic could improve 42 health conditions – and make 19 worse
A major US study says weight-loss jabs can increase the risk of haemorrhoids, low blood pressure, tendonitis and osteoarthritis.
- Joe Pinkstone
The five health benefits of slow running
Build endurance, burn fat, improve heart health and reduce risk of injury – plus you can chat while you jog.
- Emily Craig
The future of health
The inaugural Australian Financial Review Healthcare Summit, where pioneering minds and breakthrough treatments converge with critical policy decisions.
The scientist-turned-banker’s mission to fund cancer breakthrough
Alan Taylor has swapped his early years on the sports field and a stint as an investment banker for the boardroom, in his quest to get medical breakthroughs to patients.
- Michael Smith
Exclusive Subscriber Offer - Healthcare Summit 2025
Financial Review subscribers receive a 15% discount on in-person tickets to this event on April 7, 2025.
This ‘sonic waterbed’ promises to beat jet lag and poor sleep
Reporter Michael Smith takes a trip towards better sleep with an immersive cocktail of light, sound and vibration therapy from the comfort of a high-tech waterbed.
- Michael Smith
Spray-on skin hopeful Avita Medical nosedives 19pc on revenue miss
The regenerative medicine company disappointed its shareholders with a revenue miss that has dragged down full-year results as hospitals slowed buying.
- Kanika Sood
Why upmarket gyms are taking on country-club vibes
Playing on the nostalgia for Ivy League-coded preppiness, these athletic spaces veer sharply away from the sleek aesthetic long favoured by fitness chains.
- Sarah Wood González
- Exclusive
- Healthcare
Global pharma giants push for weight-loss drugs to be added to PBS
Eli Lilly will seek to have Mounjaro listed on the scheme this year. If successful, it would mean taxpayer subsidies for the popular obesity treatment.
- Michael Smith
December 2024
Millions in debt, but this CSL challenger is still tapping investors
Aegros has promised new management and a new board in the hopes of wooing investors. But its promising blood plasma technology looks further away than ever.
- Yolanda Redrup
- Investigation
- Healthcare
Diagnosed in 10 minutes. Inside Australia’s ADHD industrial complex
Prescriptions for ADHD drugs have doubled in the past four years and private clinics are cashing in. Doctors fear profits are taking priority over patient care.
- Michael Smith
Sigma clears hurdle in $30b Chemist Warehouse deal
The independent expert commissioned by Sigma Healthcare to review its $30b Chemist Warehouse merger says the deal is fair and reasonable.
- Michael Smith
Mesoblast shares rocket on FDA approval, but CEO says risks remain
FDA approval for Mesoblast’s cell therapy used to treat children for complications that can occur during bone marrow transplants is a breakthrough for the biotech.
- Michael Smith
TPG Capital weighs new options for Novotech’s future
Street Talk understands TPG is weighing up a bunch of complicated options for its $4 billion clinical research group.
- Sarah Thompson, Kanika Sood and Emma Rapaport
- Opinion
- Chanticleer
Only one thing can end the $22b private health war
Brookfield’s latest fund injection into Healthscope is more evidence of the need for the government to step in to try to resolve a desperate and messy issue.
- James Thomson
- Opinion
- Health insurance
The CEO, not the shooter, is the real working-class hero
Brian Thompson, who was fatally shot in New York, is a model for how a talented, determined man from humble roots can rise to the top of corporate life.
- Bret Stephens
Affinity PE closes $515m Lumus Imaging debt deal
GIlbert + Tobin’s banking group head Gail Christopher was on hand to support Affinity with the negotiations.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Bupa offers Healthscope doctors payments to switch hospitals
The health insurer giant is offering Healthscope doctors up to $500 per patient if they move to another hospital.
- Michael Smith
Sonic Healthcare to buy German lab group for $700m
Pathology giant Sonic Healthcare is buying one of Germany’s top medical lab groups as it seeks to expand its market share in Europe.
- Michael Smith
Bain Capital kicks off dividend recap at aged care biz Estia Health
Sources said the loans are being provided by infrastructure-focused investors including Keppel Infrastructure, Stonepeak and Pacific Equity Partners.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Health insurers tricking members with secret premium rises: Labor
Health Minister Mark Butler says insurers are exploiting a loophole that allows them to charge hundreds more by replacing products with more expensive new ones.
- Michael Smith
- Exclusive
- Healthcare
Doctors say health insurers have too much control over home care
The AMA is warning that Australia is at risk of adopting “US-style managed care” where insurance companies call all the shots.
- Michael Smith
